Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Cash Flows (Unaudited)

v2.4.0.8
Consolidated Statements of Cash Flows (Unaudited) (USD $)
9 Months Ended
Sep. 30, 2013
Sep. 30, 2012
Cash Flows from Operating Activities:    
Net loss $ (692,027) $ (1,708,794)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 613,834 521,533
Amortization of debt discount 12,992   
Non cash interest expense 41,589 33,288
Deferred compensation 4,390 29,111
Allowance for doubtful accounts (11,801) 10,000
Stock based compensation 169,986 196,986
Loss from joint venture 17,452   
Changes in Assets and Liabilities:    
Accounts receivable (55,490) (75,595)
Other assets 1,948 (187)
Prepaid expenses and other current assets 118,592 5,212
Employee Loan (20,300)   
Accounts payable and accrued expenses 14,591 168,679
Deferred revenue (65,866) 10,405
Deferred rent (6,623) (4,922)
Net Cash Provided by (Used in) Operating Activities 143,267 (814,284)
Cash Flows from Investing Activities:    
Capital expenditures (179,048) (99,827)
Investment in joint venture (21,300)   
Net Cash Used in Investing Activities (200,348) (99,827)
Cash Flows from Financing Activities:    
Due to related party 34,836   
Proceeds from the issuance of common stock    500,000
Issuance of convertible debt 200,000 500,000
Repayments of capital lease obligations (198,472) (152,729)
Repayments of loan obligations    (46,047)
Repayment of contingent consideration (7,762)   
Advances from officer 17,331 128,379
Net Cash Provided by Financing Activities 45,933 929,603
Decrease in Cash and Cash Equivalents (11,148) 15,492
Cash and Cash Equivalents, Beginning of Period 72,756 168,490
Cash and Cash Equivalents, End of Period 61,608 183,982
Cash paid for interest 10,597 2,968
Cash paid for income taxes      
Non cash investing and financing activities:    
Accrual of preferred stock dividend 37,500 37,500
Warrants issued with convertible debt 35,702   
Fixed assets acquired under capital leases    309,297
Stock issued for deferred compensation    $ 42,500